Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 29.20
0.00 (0.00%)
Aug 13, 2026, 4:13 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 40.11 million as of August 13, 2026. Its market cap has increased by 165.45% in one year.
Market Cap
40.11M
Enterprise Value
38.82M
Revenue
20.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.20
ChartMarket Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 40.11M, a decrease of -64.74%. That is a compound annual growth rate of -11.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 40.11M | 192.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 91.77M |
| OncoZenge AB | 87.24M |
| Ascelia Pharma AB | 77.45M |
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 73.02M |
| Pila Pharma AB | 59.16M |
| Disruptive Pharma AB | 57.61M |
| 2cureX AB | 51.68M |